Kewaunee ScientificKEQU
KEQU
0
Funds holding %
of 7,398 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
200% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 4
111% more capital invested
Capital invested by funds: $36.1M [Q3] → $76.2M (+$40.1M) [Q4]
23% more funds holding
Funds holding: 35 [Q3] → 43 (+8) [Q4]
5.17% more ownership
Funds ownership: 37.79% [Q3] → 42.97% (+5.17%) [Q4]
9% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 11
Research analyst outlook
We haven’t received any recent analyst ratings for KEQU.
Financial journalist opinion
Based on 3 articles about KEQU published over the past 30 days
Positive
Zacks Investment Research
1 week ago
KEQU Reports Y/Y Earnings Decline in Q3 Despite Strong Sales Growth
Kewaunee Scientific's revenues rise 43.6% in Q3, but profits decline due to higher expenses and Nu Aire acquisition costs. Backlog hits $221.6 million.

Neutral
PRNewsWire
2 weeks ago
Kewaunee Scientific Announces Amendment to Share Repurchase Program
STATESVILLE, N.C. , March 12, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced an amendment to its existing share repurchase program.

Neutral
PRNewsWire
2 weeks ago
Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2025
STATESVILLE, N.C. , March 12, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its third quarter ended January 31, 2025.

Neutral
PRNewsWire
1 month ago
Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2025
STATESVILLE, N.C. , Feb. 26, 2025 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its third quarter fiscal year 2025 financial results on Wednesday, March 12, 2025 after the close of trading.

Positive
Seeking Alpha
3 months ago
Kewaunee Scientific: Growth Has Been Priced In After Q2 2025 Report
Kewaunee Scientific manufactures laboratory furniture and equipment, a growing market driven by the need for advancements in healthcare. Since 2022, the company has focused on improving its margins through stop selling directly in some markets where the company had to focus on producing and selling. This has been reflected in the expansion of margins, but growth has been mid-single digit, and I think it can continue like this in the future.

Neutral
Zacks Investment Research
3 months ago
Kewaunee Scientific's Q2 Earnings Rise Y/Y Despite Sales Decline
KEQU reports fiscal Q2 earnings growth, driven by strong domestic demand and strategic acquisition of Nu Aire despite revenue challenges.

Neutral
PRNewsWire
3 months ago
Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2025
STATESVILLE, N.C. , Dec. 11, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its second quarter ended October 31, 2024.

Neutral
PRNewsWire
4 months ago
Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2025
STATESVILLE, N.C. , Nov. 27, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its second quarter fiscal year 2025 financial results on Wednesday, December 11, 2024 after the close of trading.

Neutral
PRNewsWire
4 months ago
Kewaunee Scientific Corporation Completes Acquisition of Nu Aire
STATESVILLE, N.C. , Nov. 1, 2024 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) Kewaunee Scientific Corporation ("Kewaunee"), a leader in laboratory furniture and technical product design and manufacturing, today announced the successful acquisition of Nu Aire, a Minneapolis-based company, for $55 million, subject to certain adjustments for debt, cash, transaction expenses, and net working capital.

Negative
Zacks Investment Research
6 months ago
Zacks Initiates Coverage of Kewaunee Scientific With Neutral Recommendation
Discover why Zacks rates KEQU as "Neutral," being the first on Wall Street to initiate the coverage of the stock. Explore KEQU's strong order backlog and stable domestic growth amid international challenges and competitive pressures in the laboratory furniture market.

Charts implemented using Lightweight Charts™